Bristol Myers Squibb Health Equity Initiatives is a grant from the Bristol Myers Squibb Foundation that funds programs working to remove barriers to quality care for medically underserved and diverse patient populations. Grants ranging from $50,000 to $250,000 support disease awareness and education, health equity initiatives, and other programs aligned with BMS's therapeutic areas of interest including oncology, hematology, immunology, and cardiovascular disease. The foundation accepts applications throughout the year and prioritizes initiatives that improve access to care and advance health equity for all. Eligible applicants are U.S.-based 501(c)(3) nonprofit organizations or academic institutions. International funding opportunities may differ.

Bristol Myers Squibb Foundation Community Giving Program is a grant from Bristol Myers Squibb Foundation Inc. that funds IRS-qualified 501(c)(3) nonprofit organizations working to improve health equity and patient outcomes in communities where BMS employees reside. The program accepts applications year-round and supports initiatives aligned with BMS therapeutic areas including oncology (lymphoma, multiple myeloma, leukemia), cardiovascular disease (atrial fibrillation, stroke prevention, VTE), immunology (lupus, multiple sclerosis, psoriasis), and cell therapy. Eligible organizations may also apply for independent medical education grants, disease awareness and education programs, and health equity policy advocacy initiatives. Funded organizations must be in compliance with applicable law, and BMS does not support programs that conflict with its legal obligations.

Bristol-Myers Squibb Foundation Grants (reducing health disparities) is sponsored by Bristol-Myers Squibb Foundation. The Bristol-Myers Squibb Foundation runs grant schemes to reduce health disparities in key areas, including HIV/AIDS in Africa. While not exclusively cancer research, it aligns with broader health initiatives in the region where oncology is a significant concern.

Bristol-Myers Squibb Foundation Grants is sponsored by Bristol-Myers Squibb Foundation. The Bristol-Myers Squibb Foundation focuses on reducing health disparities in several key areas, including cancer in the United States, hepatitis B and C in China and India, HIV and comorbid diseases in Sub-Saharan Africa, veterans' mental health and well-being in the United States, and type 2 diabetes in the United States, China, and India. They also work to expand access to specialty care for vulnerable populations with lung cancer, skin cancer, HIV, or cardiovascular disease in the United States.

Bristol Myers Squibb Corporate Giving & Independent Medical Education Funding is sponsored by Bristol Myers Squibb. BMS provides corporate grants and independent medical education (IME) support focusing on health equity initiatives and priority oncology/hematology areas to advance patient care, remove barriers to treatment, and improve outcomes for diverse and underserved populations.

Bristol Myers Squibb Corporate Giving & Independent Medical Education Funding - Oncology/Hematology is sponsored by Bristol Myers Squibb. Provides year-round corporate grants and independent medical education (IME) support, focusing on health equity initiatives and priority oncology/hematology areas to advance patient care, remove barriers to treatment, and improve outcomes for diverse and underserved populations. Supports program development, educational materials, conference participation, patient-focused initiatives, community outreach, and advocacy projects.